SCHEMBL3244970

SCHEMBL3244970

CC(C)C(OC(=O)c1c(I)c(CC(N)=O)c(I)c(CC(N)=O)c1I)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL333133 0.72 LMNA (0.46)
SCHEMBL5805414 0.64 LMNA (0.38)
SCHEMBL25763520 0.61 TSHR (0.48)
SCHEMBL13615583 0.61 TSHR (0.48)
SCHEMBL17642560 0.59
SCHEMBL17665115 0.57
SCHEMBL17352445 0.57
SCHEMBL20457961 0.56 ALOX15 (0.39)
SCHEMBL18746008 0.55
SCHEMBL23224418 0.54 SMN1; SMN2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009007-A1 Non-covalent modification of microparticles and process of preparing same BAXTER INTERNATIONAL INC. (US) 2010-01-14 US disclosed
WO-2010006194-A2 NON-COVALENT MODIFICATION OF MICROPARTICLES AND PROCESS OF PREPARING SAME BAXTER INTERNATIONAL INC. (US) 2010-01-14 WO disclosed
US-20060260777-A1 SURFACE-MODIFIED MICROPARTICLES AND METHODS OF FORMING AND USING THE SAME BAXTER HEALTHCARE S.A. (CH) 2006-11-23 US disclosed